This Corporate Presentation - and the showcasing of the huge
opportunities which can be available with the Imugene package
really demonstrates how undervalued this stock is; and no doubt
will be considered an attractive investment by those companies
searching for a rich source of income, with any of Imugene's
new age treatments
